{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:59:06Z","timestamp":1781038746950,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013904","name":"Swiss Bridge Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["310850\/2022-3"],"award-info":[{"award-number":["310850\/2022-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024786","name":"Instituto Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/210.466\/2024"],"award-info":[{"award-number":["E-26\/210.466\/2024"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018824","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Neuroimunomodula\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Institute for Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humimm.2026.111740","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:07:08Z","timestamp":1776118028000},"page":"111740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PD-1 high expression in T lymphocytes correlates with decreased survival in childhood B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"87","author":[{"given":"Clara de Oliveira","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaislan Igor da","family":"Silva Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Carlos","family":"Aragao-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa de Souza","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-1506","authenticated-orcid":false,"given":"Daniella Areas","family":"Mendes-da-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda Pereira","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Pombo-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-140X","authenticated-orcid":false,"given":"Eugenia","family":"Terra-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111740_b0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.111740_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101193","article-title":"Molecular markers in ALL: clinical implications","volume":"33","author":"Kimura","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.humimm.2026.111740_b0015","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.3390\/cancers15133346","article-title":"Acute lymphoblastic leukemia immunotherapy treatment: now, next, and beyond","volume":"15","author":"Aureli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2026.111740_b0020","first-page":"1329","article-title":"Precision medicine for acute lymphoblastic leukemia in children: a review","volume":"11","author":"Ray","year":"2024","journal-title":"Children (basel)."},{"key":"10.1016\/j.humimm.2026.111740_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1179913","article-title":"Editorial: novel biomarkers for predicting response to cancer immunotherapy","volume":"14","author":"Huangfu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111740_b0030","article-title":"The tumor microenvironment in leukemia: molecular pathways of immune evasion","volume":"17","author":"Zhu","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111740_b0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.humimm.2026.111740_b0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2026.111740_b0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De novo epigenetic programs inhibit PD-1 blockade\u2013mediated T cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2026.111740_b0050","doi-asserted-by":"crossref","unstructured":"R. Alaggio, C. Amador, I. Anagnostopoulos, A.D. Attygalle, I.B.O. Araujo, E. Berti, et al., The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms, Leukemia. 36 (2022) 1720\u20131748. Doi: 10.1038\/s41375-022-01620-2.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"10.1016\/j.humimm.2026.111740_b0055","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1200\/JCO.22.01760","article-title":"Childhood acute lymphoblastic leukemia: results of the randomized acute lymphoblastic leukemia intercontinental Berlin\u2013Frankfurt\u2013M\u00fcnster 2009 trial","volume":"41","author":"Campbell","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2026.111740_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.htct.2022.06.008","article-title":"The landscape of genetic mutations in childhood acute lymphoblastic leukemia in Brazil","volume":"45","author":"Noronha","year":"2023","journal-title":"Hematol Transfus Cell Ther."},{"key":"10.1016\/j.humimm.2026.111740_b0065","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.humimm.2026.111740_b0070","doi-asserted-by":"crossref","unstructured":"S. Zhou, Y. Wang, D.R. Wakhloo, A. Dikshit, L.C. Wang, M. Srinivasan, Spatial multiomics reveals T-cell activation and exhaustion states in the tumor microenvironment, J Immunol. 214 (2025) vkaf283.1251. Doi: 10.1093\/jimmun\/vkaf283.1251.","DOI":"10.1093\/jimmun\/vkaf283.1251"},{"key":"10.1016\/j.humimm.2026.111740_b0075","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/ijlh.14472","article-title":"Programmed cell death-1 and programmed cell death ligand-1 in childhood acute B-lymphoblastic leukemia: expression and significance as biomarker","volume":"47","author":"Allam","year":"2025","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.humimm.2026.111740_b0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s40001-023-01352-8","article-title":"Clinical implications of aberrant PD-1 expression for acute leukemia prognosis","volume":"28","author":"Ruan","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.humimm.2026.111740_b0085","doi-asserted-by":"crossref","first-page":"76902","DOI":"10.18632\/oncotarget.12357","article-title":"T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80\/CD86 on leukemic blasts","volume":"7","author":"Feucht","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.111740_b0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2026.111740_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.111740_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1709852","article-title":"Terminally exhausted CD8+ T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology","volume":"16","author":"Guo","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111740_b0105","first-page":"61","article-title":"Beyond PD-1\/PD-L1: new immune checkpoints and therapeutic combinations in cancer immunotherapy, Medicine","volume":"2","author":"Li","year":"2026","journal-title":"Bulletin"},{"key":"10.1016\/j.humimm.2026.111740_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2025.108148","article-title":"Efficacy and safety of PD-1\/PD-L1 inhibitors in combination with chemotherapy or CAR-T cells for relapsed\/refractory acute lymphoblastic leukemia: a multicenter phase II trial","volume":"160","author":"Zou","year":"2026","journal-title":"Leuk. Res."},{"key":"10.1016\/j.humimm.2026.111740_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100991","article-title":"Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment","volume":"57","author":"Serroukh","year":"2023","journal-title":"Blood Rev."},{"key":"10.1016\/j.humimm.2026.111740_b0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J. Immunother. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:25:04Z","timestamp":1781036704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0198885926000868"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111740","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 high expression in T lymphocytes correlates with decreased survival in childhood B-cell precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111740"}}